ClinicalTrials.gg
CompletedNCT00639093Updated Jul 2, 2012Results posted

A Virtual Arm to Stop Smoking

An interventional study of psychoeducational / motivational combined with crushing and psychoeducational / motivational combined with control in Cigarette Smoking, sponsored by Universite du Quebec en Outaouais. Completed at 1 site in Canada. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-07-02.

Sponsored by Universite du Quebec en Outaouais · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
91
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The investigators reported in a pilot study presented at last year's Cybertherapy Conference (Girard \& Turcotte, 2007) that using an action-cue exposure strategy in virtual reality (ACE-VR; crushing virtual cigarettes) might be useful in the treatment of tobacco addiction.

The investigators are pursuing research in this area with a randomized control trial based on 90 smokers who will receive a brief psychosocial smoking cessation program (25 people are enrolled so far and we expect to finish the study before the conference). During the first four weeks of an eight-session psychoeducational and motivational program, all participants will be immersed in VR. During the immersions in VR, 45 of the participants will use a virtual arm to catch and crush virtual cigarettes. The other half of the sample will use the virtual arm to catch virtual fruits (control condition).

The smoking frequency, and abstinence, will be assessed with a daily diary and exhaled carbon monoxide tests (the CO2 tests will provide an objective confirmation of the abstinence reported in the diaries). The success the program will be compared based on the number of subjects who quitted or reduced their smoking frequency. The severity of addiction will be assessed with two questionnaires, the Fagerstrom and the Horn tests. Craving and withdrawal effects will be measured with the Minnesota Nicotine Withdrawal Scale (MNWS) and the Brief Questionnaire of Smoking Urges (QSU-Brief) at the baseline and at the visits from weeks 1 through 4, 6, 12 and at the end of the program. Before the VR immersion, the Immersive Tendencies Questionnaire will be administered and after each VR session participants will fill two questionnaires addressing presence and cybersickness. The comparative impact of both treatments will be tested with repeated measures ANOVAs (and planned contrasts) with sufficient power to detect medium effect sizes.

The main goal of our study is show that crushing virtual cigarettes can boost the impact of a behavioural program dedicated to cigarette addiction.

Read the detailed description

A detailed description is available, in French, by contacting stephane.bouchard@uqo.ca.

02

Conditions studied

  • Cigarette Smoking

Browse trials for

Keywords

  • cigarette smoking
  • psychoeducational and motivational program
  • virtual reality
03

In context

Cigarette Smoking

132 studies on the registry are indexed under Cigarette Smoking; 60 are open to participants now.

This study's enrollment of 91 is close to the median of 94 across 114 interventional studies indexed under Cigarette Smoking.

Browse Cigarette Smoking studies →

Lead sponsor

Universite du Quebec en Outaouais is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult smoker
  • aged 18 - 65
  • willing to stop smoking
  • at least 10 cigarettes per day in the last year

Exclusion criteria

Exclusion Criteria:

  • receiving concomitant treatment for smoking (e.g., patches or varenicline)
  • weight problems : Body Mass Index \< 15 kg or > 45.5 kg
  • suffering from a mental disorder, such as major depression, schizophrenia, etc.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
91 participants (actual)

Study arms

  • Experimental
    1

    All participants will receive an eight-session psychoeducational and motivational program. During the first four weeks, all participants will be immersed in virtual reality (VR). During the immersions in VR, 45 of the participants will use a virtual reality arm to catch and crush virtual cigarettes (on a computer).

    Behavioral: psychoeducational / motivational combined with crushing

  • Active comparator
    2

    All participants will receive an eight-session psychoeducational and motivational program. During the first four weeks, all participants will be immersed in virtual reality (VR). During the immersions in VR, the 45 participants in the control condition will use a virtual reality arm to catch and crush virtual fruits (on a computer).

    Behavioral: psychoeducational / motivational combined with control

Interventions

  • Behavioralpsychoeducational / motivational combined with crushing

    All participants will receive an eight-session psychoeducational and motivational program. During the first four weeks, all participants will be immersed in virtual reality (VR). During the immersions in VR, 45 of the participants will use a virtual reality arm to catch and crush virtual cigarettes (on a computer).

  • Behavioralpsychoeducational / motivational combined with control

    All participants will receive an eight-session psychoeducational and motivational program. During the first four weeks, all participants will be immersed in virtual reality (VR). During the immersions in VR, the 45 participants in the control condition will use a virtual reality arm to catch and crush virtual fruits (on a computer).

06

What researchers measure

Primary outcomes

  1. Self-report Measure of Abstinence in the Last 7 Days, Averaged Over Four Weeks, and Confirmed by Urine Samples.

    Participants completed a daily diary to record the number cigarettes smoked during the day. No cigarette smoked during 7 days = abstinence. To be counted as real abstinence, the participant had to smoke zero cigarettes during four weeks and confirmed by zero nicoting in the unrine sample. Six measurement times were used to assess if zero cigarettes has been smoked in the last 4 weeks prior to the study (Week 1), during the first four weeks (Week 4 measurement point) and so on for a blok of four weeks ending at each measurement point (e.g., four weeks before the 12-month follow-up).

    Time frame: Weeks 1, 4, 6, 12, 24 and 12-month follow-up

Secondary outcomes

  1. Tiffany's Urge to Smoke Questionnaire

    Time frame: Weeks 1, 4, 6, 12, 24 and 12-month follow-up

07

Results

Posted Jul 31, 2009

Participant flow

Medical clinic in the province of Quebec.

Participant flow — Overall Study
MilestoneVR - CigarettesVR - Balls (Control)
Started4546
Completed4546
Not completed00

Outcome measures

PrimarySelf-report Measure of Abstinence in the Last 7 Days, Averaged Over Four Weeks, and Confirmed by Urine Samples.

Participants completed a daily diary to record the number cigarettes smoked during the day. No cigarette smoked during 7 days = abstinence. To be counted as real abstinence, the participant had to smoke zero cigarettes during four weeks and confirmed by zero nicoting in the unrine sample. Six measurement times were used to assess if zero cigarettes has been smoked in the last 4 weeks prior to the study (Week 1), during the first four weeks (Week 4 measurement point) and so on for a blok of four weeks ending at each measurement point (e.g., four weeks before the 12-month follow-up).

Time frame:
Weeks 1, 4, 6, 12, 24 and 12-month follow-up
Reported as:
Number · participants
Self-report Measure of Abstinence in the Last 7 Days, Averaged Over Four Weeks, and Confirmed by Urine Samples.
participantsVR - CigarettesVR - Balls (Control)
Self-report Measure of Abstinence in the Last 7 Days, Averaged Over Four Weeks, and Confirmed by Urine Samples.4546
SecondaryTiffany's Urge to Smoke Questionnaire
Time frame:
Weeks 1, 4, 6, 12, 24 and 12-month follow-up

Results for this outcome have not been posted.

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
VR - Cigarettes—0/45 (0%)0/45 (0%)
VR - Balls (Control)—0/46 (0%)0/46 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)VR - CigarettesVR - Balls (Control)Total
<=18 years000
Between 18 and 65 years454691
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)VR - CigarettesVR - Balls (Control)Total
Female252651
Male202040
Region of Enrollment
Region of Enrollment(participants)VR - CigarettesVR - Balls (Control)Total
Canada454691
Nicotine addiction
Nicotine addiction(Participants)VR - CigarettesVR - Balls (Control)Total
Number454691
08

Study locations

1 site
  • GRAP - Clinique de psychologie au travail
    Jonquière, Quebec G7X 0A4, Canada
09

References and documents

Publications

  • Girard, B., & Turcotte, V. (2007). A virtual arm to stop smoking, a perceptual learning experiment. In N. Appel & H. Hoffman (Chairs), Addictions. Symposium presented at the Cybertherapy 12 Conference, in June in Washington, D.C.
  • Martin RA, Rohsenow DJ, MacKinnon SV, Abrams DB, Monti PM. Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment. Drug Alcohol Depend. 2006 Jun 9;83(1):73-8. doi: 10.1016/j.drugalcdep.2005.10.013. Epub 2005 Nov 28. PubMed 16314049 ↗
  • Girard B, Turcotte V, Bouchard S, Girard B. Crushing virtual cigarettes reduces tobacco addiction and treatment discontinuation. Cyberpsychol Behav. 2009 Oct;12(5):477-83. doi: 10.1089/cpb.2009.0118. PubMed 19817561 ↗
10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2008, a primary completion of Jun 2008 and a completion of Jun 2009. It does not say whether these dates are actual or estimated.

Results were first posted in Jul 2009, 1 year 1 month after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 12, 2008
First posted
Mar 19, 2008
Start
Mar 2008
Primary completionActual
Jun 2008
CompletionActual
Jun 2009
Results first posted
Jul 31, 2009
Last update
Jul 2, 2012
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 2, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00639093
Lead sponsor
Universite du Quebec en Outaouais
Responsible party
Stephane Bouchard (Professor, Universite du Quebec en Outaouais) — Principal investigator
First posted
Mar 19, 2008
Start date
Mar 2008
Primary completion
Jun 2008
Completion
Jun 2009
Results posted
Jul 31, 2009
Last update
Jul 2, 2012

Study contacts

Benoit Girard, M.D.
principal investigator · G.R.A.P.
Stephane Bouchard, Ph.D.
study chair · U.Q.O.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion